CALCIUM CARBONATE- calcium carbonate suspension 
PAI Holdings, LLC

----------

Calcium Carbonate

Drug Facts

Active ingredient (in each 5 mL teaspoonful)

Calcium Carbonate 1250 mg
(Equivalent to 500 mg elemental Calcium)

Purpose

Antacid

Uses

Relieves:

Warnings

Ask a doctor or pharmacist before use if you are taking a prescription drug. Antacids may interact with certain prescription drugs.

When using this product, do not take more than 6 teaspoonfuls (30 mL) in a 24-hour period or use the maximum dosage for more than 2 weeks.

Keep out of reach of children.

Directions

Other information

NDC 0121-0766-16:16 fl oz (473 mL) bottle
NDC 0121-4766-05:5 mL unit dose cup, in a tray of ten cups.

Inactive ingredients

calcium saccharin, citric acid, D&C Red No. 33, FD&C Red No. 40, flavoring, glycerin, methylparaben, propylene glycol, propylparaben, purified water, sorbitol and xanthan gum.

Questions or comments?

Call 1-800-845-8210.

You may also report serious side effects to this phone number.

MANUFACTURED BY

Pharmaceutical Associates, Inc. Greenville, SC 29605

R07/20

PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label

NDC 0121-0766-16

Quality ®
Value

Calcium Carbonate
Oral Suspension

1250 mg/5 mL

Maximum Strength
ANTACID

Daily source of calcium

SUGAR FREE / ALCOHOL FREE
SODIUM FREE

16 fl oz (473 mL)

Pharmaceutical
Associates, Inc.
Greenville, SC 29605

Principal Display Panel - 473 mL Bottle Label

PRINCIPAL DISPLAY PANEL - 5 mL Cup Tray Label

Delivers 5 mL

NDC 0121-4766-05

Calcium Carbonate Oral Suspension

1250 mg/5 mL

(equivalent to 500 mg of elemental Calcium)

ANTACID – SHAKE WELL

Package Not Child-Reistant

Pharmaceutical Associates, Inc.

Greenville, SC 29605

SEE INSERT

A0766051021

PRINCIPAL DISPLAY PANEL - 5 mL Cup Tray Label
CALCIUM CARBONATE 
calcium carbonate suspension
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0121-0766
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB, CARBONATE ION - UNII:7UJQ5OPE7D) CALCIUM CARBONATE1250 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
SACCHARIN CALCIUM (UNII: 5101OP7P2I)  
WATER (UNII: 059QF0KO0R)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SORBITOL (UNII: 506T60A25R)  
GLYCERIN (UNII: PDC6A3C0OX)  
XANTHAN GUM (UNII: TTV12P4NEE)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
Product Characteristics
ColorpinkScore    
ShapeSize
FlavorBUBBLE GUMImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0121-0766-1612 in 1 CASE12/01/2004
1473 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00112/01/2004
CALCIUM CARBONATE 
calcium carbonate suspension
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0121-4766
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM CARBONATE (UNII: H0G9379FGK) (CALCIUM CATION - UNII:2M83C4R6ZB, CARBONATE ION - UNII:7UJQ5OPE7D) CALCIUM CARBONATE1250 mg  in 5 mL
Inactive Ingredients
Ingredient NameStrength
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SORBITOL (UNII: 506T60A25R)  
GLYCERIN (UNII: PDC6A3C0OX)  
XANTHAN GUM (UNII: TTV12P4NEE)  
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
FD&C RED NO. 40 (UNII: WZB9127XOA)  
D&C RED NO. 33 (UNII: 9DBA0SBB0L)  
SACCHARIN CALCIUM (UNII: 5101OP7P2I)  
WATER (UNII: 059QF0KO0R)  
Product Characteristics
ColorpinkScore    
ShapeSize
FlavorBUBBLE GUMImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0121-4766-054 in 1 CASE12/01/2004
110 in 1 TRAY
15 mL in 1 CUP, UNIT-DOSE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00112/01/2004
Labeler - PAI Holdings, LLC (044940096)
Establishment
NameAddressID/FEIBusiness Operations
PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma097630693manufacture(0121-0766, 0121-4766)

Revised: 11/2023
Document Id: 8ff807ab-6224-42f0-b0bb-f28d518bbc52
Set id: d89f3184-7081-4e16-a504-9214283891f6
Version: 7
Effective Time: 20231116
 
PAI Holdings, LLC